Alyeska Investment Group
GOSS icon

Alyeska Investment Group’s Gossamer Bio GOSS Stock Holding History

Alyeska Investment Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Hold
2,051,442
– – ﹤0.01% 635
2026
Q1 		$674K Buy
2,051,442
+1,142,355
+126% +$1.8M ﹤0.01% 585
2025
Q4 		$2.82M Sell
909,087
-1,000,000
-52% -$2.85M 0.01% 502
2025
Q3 		$5.02M Sell
1,909,087
-2,550,000
-57% -$5.62M 0.02% 454
2025
Q2 		$5.48M Buy
4,459,087
+295,353
+7% +$322K 0.02% 413
2025
Q1 		$4.58M Sell
4,163,734
-4,644,780
-53% -$5.37M 0.02% 369
2024
Q4 		$7.97M Buy
8,808,514
+3,041,058
+53% +$2.61M 0.03% 362
2024
Q3 		$5.69M Buy
5,767,456
+279,940
+5% +$269K 0.03% 339
2024
Q2 		$4.94M Buy
+5,487,516
New +$4.11M 0.03% 341
2024
Q1 		– Sell
-2,913,216
Closed -$2.66M – 525
2023
Q4 		$2.66M Sell
2,913,216
-3,890,284
-57% -$2.87M 0.02% 351
2023
Q3 		$5.67M Buy
+6,803,500
New +$7.84M 0.04% 331
2022
Q3 		– Sell
-114,608
Closed -$959K – 425
2022
Q2 		$959K Sell
114,608
-50,000
-30% -$387K 0.01% 500
2022
Q1 		$1.43M Buy
+164,608
New +$1.59M 0.02% 473
2021
Q4 		– Sell
-120,066
Closed -$1.51M – 659
2021
Q3 		$1.51M Sell
120,066
-650,000
-84% -$5.98M 0.02% 539
2021
Q2 		$6.25M Buy
770,066
+50,000
+7% +$434K 0.07% 296
2021
Q1 		$6.66M Buy
720,066
+182,426
+34% +$1.84M 0.09% 272
2020
Q4 		$5.2M Sell
537,640
-635,661
-54% -$6.26M 0.07% 268
2020
Q3 		$14.6M Sell
1,173,301
-321,321
-21% -$4.26M 0.22% 145
2020
Q2 		$19.4M Buy
1,494,622
+1,017,784
+213% +$12.8M 0.29% 125
2020
Q1 		$4.84M Buy
476,838
+98,902
+26% +$1.29M 0.1% 191
2019
Q4 		$5.91M Buy
377,936
+358,663
+1,861% +$7.22M 0.08% 212
2019
Q3 		$324K Sell
19,273
-82,591
-81% -$1.64M ﹤0.01% 373
2019
Q2 		$2.26M Sell
101,864
-50,619
-33% -$968K 0.03% 309
2019
Q1 		$3.3M Buy
+152,483
New +$3.18M 0.04% 250

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Alyeska Investment Group's GOSS Position: Q2 2026 in Review

Alyeska Investment Group held its Gossamer Bio (GOSS) position steady in Q2 2026 at 2,051,442 shares worth $338K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Alyeska Investment Group first reported a position in GOSS in Q1 2019 and has held it in 24 quarters since. The position peaked at $19.4M in Q2 2020. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Alyeska Investment Group held 2,051,442 shares of Gossamer Bio worth $338K as of Q2 2026.
  • Alyeska Investment Group left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #635 holding.
  • Alyeska Investment Group first reported a position in Gossamer Bio in Q1 2019 and has held it in 24 quarters since.
  • Alyeska Investment Group's Gossamer Bio position peaked at $19.4M in Q2 2020.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.